Asset Details
Do you wish to reserve the book?
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
Do you wish to request the book?
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
2022
Overview
In this post-hoc analysis of data from a randomised clinical trial, we compared the effect of liraglutide to placebo on markers of insulin secretion in persons with type 2 diabetes treated with multiple daily insulin injections. Liraglutide increased insulin secretion, measured by C-peptide, by 19% after 24 weeks of treatment.
EudraCT 2012-001941-42.
•In T2D patients with MDI, liraglutide increased C-peptide compared to placebo.•Liraglutide decreased the proinsulin/C-peptide ratio compared to placebo.•Liraglutide may improve beta cell function in T2DM patients who use MDI.
Publisher
Elsevier Inc,Elsevier Limited
